TP53 and non-small cell lung carcinoma: In the Genomics, Evidence, Neoplasia, Information, Exchange Cohort v15.1‐public database [4], 4335 patients with NSCLC had EGFR mutations, 7674 had TP53 mutations, and 178 had CUL3 mutations.